Frederick Ehlert, MD
Clinical Cardiac Electrophysiology · New York, NYNPI 1871598615
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Philips North America LLC at 45.9% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NY, where the typical reported total is $18,433.
Across 287 payments — averaging $61.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$8K
- Medtronic$2K
- Boston Scientific$2K
- Abbott$1K
- Biosense Webster, Inc.$656
- Amgen$599
- plus $3K from 21 others
Across 147 payments — averaging $3359.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$494K
- Boston Scientific$100
What the payments were for
- Consulting fees$2,00011%
- Speaking & faculty fees$9756%
- Grants$580%
- Travel & lodging$4,26424%
- Food & beverage$10,09857%
- Education$1951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 37 | $8,075 |
| Medtronic(2 entities) | 43 | $1,943 |
| Boston Scientific | 26 | $1,813 |
| Abbott | 18 | $1,245 |
| Biosense Webster, Inc. | 7 | $656 |
| Amgen | 25 | $599 |
| Johnson & Johnson | 24 | $597 |
| Novartis | 26 | $591 |
| E.r. Squibb & Sons, L.L.C. | 23 | $513 |
| Bardy Diagnostics, Inc. | 7 | $300 |
| Pfizer | 13 | $271 |
| Kiniksa Pharmaceuticals, Ltd. | 6 | $134 |
| Biotronik Inc. | 4 | $128 |
| Boehringer Ingelheim | 5 | $103 |
| Baxter Healthcare | 2 | $95 |
| Amarin Pharma, Inc. | 4 | $82 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| EBR Systems, Inc. | 1 | $61 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Irhythm Technologies, Inc. | 2 | $43 |
| Scpharmaceuticals Inc. | 1 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| Heartflow, Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Bayer | 1 | $22 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$4,078
- (9124) LM Undivided$1,566
- Spectranetics Undiv$705
- IGT Devices Und$603
- CLINICAL TRIAL PRODUCT$500
- Carto 3$422
- Assurity Pacemaker$331
- EMBLEM MRI S-ICD$284
- OCTARAY MAPPING CATHETER$283
- NUVISION ICE CATHETER$283
- VISITAG SURPOINT External Processing Unit$283
- GENERAL - THERAPIES$272
- COBALT DR MRI SURESCAN$260
- Micra$260
- CVX-300$253
- ATTAIN COMMAND + SUREVALVE$165
- AVEIR$162
- AMPLATZER AMULET$148
- Cobalt$147
- AURORA EV-ICD MRI SURESCAN$143
How this compares
$17,590 in reported general payments places this provider in the 45th percentile of 214 clinical cardiac electrophysiology providers in New York.
See all clinical cardiac electrophysiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $43,894 |
| XareltoRivaroxaban | 18 | $20,981 |
| Metoprolol Succinate | 40 | $819 |
| Flecainide Acetate | 11 | $477 |
| SotalolSotalol Hcl | 16 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $271 | $43,89434 claims |
| Johnson & JohnsonXarelto | $597 | $20,98118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 214 clinical cardiac electrophysiology providers in New York.
Other clinical cardiac electrophysiology in New York
- Vivek ReddyNew York$14.9M
- Jacob KoruthNew York$3.7M
- Srinivas DukkipatiNew York$2.7M
- Amir AhmadiNew York$789K
- Larry ChinitzNew York$448K
- James IpNew York$347K
- Nicholas SkipitarisNew York$293K
- Mohit TuragamNew York$202K
- David LauNew York$202K
- Christopher LiuNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.